Zoetis Inc. (ZTS)
USD 167.01
(-2.21%)
USD 167.01
(-2.21%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.56 Billion USD | 9.34% |
| 2022 | 2.34 Billion USD | 21.94% |
| 2021 | 1.92 Billion USD | 18.12% |
| 2020 | 1.62 Billion USD | 15.46% |
| 2019 | 1.41 Billion USD | 1.37% |
| 2018 | 1.39 Billion USD | -2.52% |
| 2017 | 1.42 Billion USD | -4.99% |
| 2016 | 1.5 Billion USD | 2.39% |
| 2015 | 1.46 Billion USD | 13.81% |
| 2014 | 1.28 Billion USD | -0.31% |
| 2013 | 1.29 Billion USD | -3.87% |
| 2012 | 1.34 Billion USD | 26.53% |
| 2011 | 1.06 Billion USD | 6.83% |
| 2010 | 995 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.65 Billion USD | 3.39% |
| 2024 Q3 | 2.41 Billion USD | -1.47% |
| 2024 Q2 | 2.45 Billion USD | -7.51% |
| 2023 Q2 | 2.7 Billion USD | 5.38% |
| 2023 Q1 | 2.56 Billion USD | 9.3% |
| 2023 Q4 | 2.56 Billion USD | -6.56% |
| 2023 Q3 | 2.74 Billion USD | 1.59% |
| 2023 FY | 2.56 Billion USD | 9.34% |
| 2022 Q2 | 2.2 Billion USD | 7.19% |
| 2022 FY | 2.34 Billion USD | 21.94% |
| 2022 Q4 | 2.34 Billion USD | 1.82% |
| 2022 Q3 | 2.3 Billion USD | 4.44% |
| 2022 Q1 | 2.05 Billion USD | 6.97% |
| 2021 FY | 1.92 Billion USD | 18.12% |
| 2021 Q4 | 1.92 Billion USD | 2.56% |
| 2021 Q3 | 1.87 Billion USD | 4.05% |
| 2021 Q2 | 1.8 Billion USD | 6.0% |
| 2021 Q1 | 1.7 Billion USD | 4.42% |
| 2020 Q3 | 1.62 Billion USD | 2.65% |
| 2020 Q2 | 1.58 Billion USD | 6.95% |
| 2020 Q4 | 1.62 Billion USD | 0.12% |
| 2020 FY | 1.62 Billion USD | 15.46% |
| 2020 Q1 | 1.48 Billion USD | 5.04% |
| 2019 Q3 | 1.43 Billion USD | 2.49% |
| 2019 FY | 1.41 Billion USD | 1.37% |
| 2019 Q4 | 1.41 Billion USD | -2.02% |
| 2019 Q1 | 1.36 Billion USD | -2.16% |
| 2019 Q2 | 1.4 Billion USD | 3.16% |
| 2018 Q3 | 1.44 Billion USD | 1.48% |
| 2018 Q4 | 1.39 Billion USD | -3.47% |
| 2018 FY | 1.39 Billion USD | -2.52% |
| 2018 Q2 | 1.42 Billion USD | -1.46% |
| 2018 Q1 | 1.44 Billion USD | 0.98% |
| 2017 Q3 | 1.49 Billion USD | -0.53% |
| 2017 Q1 | 1.53 Billion USD | 2.2% |
| 2017 FY | 1.42 Billion USD | -4.99% |
| 2017 Q4 | 1.42 Billion USD | -4.23% |
| 2017 Q2 | 1.49 Billion USD | -2.41% |
| 2016 Q2 | 1.52 Billion USD | 4.38% |
| 2016 Q3 | 1.56 Billion USD | 2.49% |
| 2016 Q4 | 1.5 Billion USD | -3.9% |
| 2016 FY | 1.5 Billion USD | 2.39% |
| 2016 Q1 | 1.46 Billion USD | -0.41% |
| 2015 Q3 | 1.4 Billion USD | -0.99% |
| 2015 FY | 1.46 Billion USD | 13.81% |
| 2015 Q4 | 1.46 Billion USD | 4.56% |
| 2015 Q2 | 1.41 Billion USD | 5.27% |
| 2015 Q1 | 1.34 Billion USD | 4.42% |
| 2014 Q3 | 1.38 Billion USD | 3.89% |
| 2014 Q4 | 1.28 Billion USD | -7.13% |
| 2014 FY | 1.28 Billion USD | -0.31% |
| 2014 Q1 | 1.31 Billion USD | 1.78% |
| 2014 Q2 | 1.33 Billion USD | 1.52% |
| 2013 Q2 | 1.25 Billion USD | 12.23% |
| 2013 Q3 | 1.29 Billion USD | 2.63% |
| 2013 Q1 | 1.12 Billion USD | -16.73% |
| 2013 FY | 1.29 Billion USD | -3.87% |
| 2013 Q4 | 1.29 Billion USD | 0.23% |
| 2012 FY | 1.34 Billion USD | 26.53% |
| 2012 Q1 | 1.23 Billion USD | 15.71% |
| 2012 Q2 | 1.17 Billion USD | -4.72% |
| 2012 Q3 | 1.27 Billion USD | 8.53% |
| 2012 Q4 | 1.34 Billion USD | 5.74% |
| 2011 Q4 | 1.06 Billion USD | 0.0% |
| 2011 FY | 1.06 Billion USD | 6.83% |
| 2010 FY | 995 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 581.38 Million USD | -341.017% |
| Bausch Health Companies Inc. | 1.54 Billion USD | -66.062% |
| Catalent, Inc. | 574 Million USD | -346.69% |
| Emergent BioSolutions Inc. | 328.9 Million USD | -679.568% |
| Elanco Animal Health Incorporated | 1.73 Billion USD | -47.781% |
| Perrigo Company plc | 1.14 Billion USD | -124.735% |
| Teva Pharmaceutical Industries Limited | 4.02 Billion USD | 36.235% |